Cargando…

Inhibitors of the Cellular Trafficking of Ricin

Throughout the last decade, efforts to identify and develop effective inhibitors of the ricin toxin have focused on targeting its N-glycosidase activity. Alternatively, molecules disrupting intracellular trafficking have been shown to block ricin toxicity. Several research teams have recently develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Julien, Bouclier, Céline, Johannes, Ludger, Gillet, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277095/
https://www.ncbi.nlm.nih.gov/pubmed/22347620
http://dx.doi.org/10.3390/toxins4010015
_version_ 1782223463523549184
author Barbier, Julien
Bouclier, Céline
Johannes, Ludger
Gillet, Daniel
author_facet Barbier, Julien
Bouclier, Céline
Johannes, Ludger
Gillet, Daniel
author_sort Barbier, Julien
collection PubMed
description Throughout the last decade, efforts to identify and develop effective inhibitors of the ricin toxin have focused on targeting its N-glycosidase activity. Alternatively, molecules disrupting intracellular trafficking have been shown to block ricin toxicity. Several research teams have recently developed high-throughput phenotypic screens for small molecules acting on the intracellular targets required for entry of ricin into cells. These screens have identified inhibitory compounds that can protect cells, and sometimes even animals against ricin. We review these newly discovered cellular inhibitors of ricin intoxication, discuss the advantages and drawbacks of chemical-genetics approaches, and address the issues to be resolved so that the therapeutic development of these small-molecule compounds can progress.
format Online
Article
Text
id pubmed-3277095
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-32770952012-02-15 Inhibitors of the Cellular Trafficking of Ricin Barbier, Julien Bouclier, Céline Johannes, Ludger Gillet, Daniel Toxins (Basel) Review Throughout the last decade, efforts to identify and develop effective inhibitors of the ricin toxin have focused on targeting its N-glycosidase activity. Alternatively, molecules disrupting intracellular trafficking have been shown to block ricin toxicity. Several research teams have recently developed high-throughput phenotypic screens for small molecules acting on the intracellular targets required for entry of ricin into cells. These screens have identified inhibitory compounds that can protect cells, and sometimes even animals against ricin. We review these newly discovered cellular inhibitors of ricin intoxication, discuss the advantages and drawbacks of chemical-genetics approaches, and address the issues to be resolved so that the therapeutic development of these small-molecule compounds can progress. MDPI 2012-01-06 /pmc/articles/PMC3277095/ /pubmed/22347620 http://dx.doi.org/10.3390/toxins4010015 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Barbier, Julien
Bouclier, Céline
Johannes, Ludger
Gillet, Daniel
Inhibitors of the Cellular Trafficking of Ricin
title Inhibitors of the Cellular Trafficking of Ricin
title_full Inhibitors of the Cellular Trafficking of Ricin
title_fullStr Inhibitors of the Cellular Trafficking of Ricin
title_full_unstemmed Inhibitors of the Cellular Trafficking of Ricin
title_short Inhibitors of the Cellular Trafficking of Ricin
title_sort inhibitors of the cellular trafficking of ricin
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277095/
https://www.ncbi.nlm.nih.gov/pubmed/22347620
http://dx.doi.org/10.3390/toxins4010015
work_keys_str_mv AT barbierjulien inhibitorsofthecellulartraffickingofricin
AT bouclierceline inhibitorsofthecellulartraffickingofricin
AT johannesludger inhibitorsofthecellulartraffickingofricin
AT gilletdaniel inhibitorsofthecellulartraffickingofricin